Featured Bonus Content
Making Heads or Tails Out of Checkpoint Inhibitor Combination Therapy for First-Line Advanced Non–Small Cell Lung Cancer
Making Heads or Tails Out of Checkpoint Inhibitor Combination Therapy for First-Line Advanced Non–Small Cell Lung Cancer.
Morning Minute - Tuesday
ASCO CEO Dr. Clifford A. Hudis wraps up our final Morning Minute with some helpful reminders, and his wish for next year.
Rhea Boyd, MD, MPH - Extended Presentation from Opening Session
Hear an extended version of Dr. Rhea Boyd's opening session presentation. Dr. Boyd is a pediatrician, public health advocate, and scholar who writes and teaches on the relationship between structural racism, inequity and health.
Morning Minute - Monday
Education Committee Chair Dr. Taofeek Kunle Owonikoko talks about how to approach the day and catch up on already aired/on demand content in this Morning Minute.
Morning Minute - Sunday
This Morning Minute features Scientific Program Chair Dr. Norah Lynn Henry who shares ideas to help you plan your day.
Candid Conversations About Death and Dying: Excerpts From The Nurse With the Purple Hair
Candid Conversations About Death and Dying: Excerpts From The Nurse With the Purple Hair.
Morning Minute - Friday
Welcome to ASCO21! Watch Friday’s Morning Minute to learn about what to expect for the first day of the meeting. ASCO President Dr. Lori J. Pierce will offer tips for making the most of your experience.
The National Cancer Institute: Leading Cancer Research in 2021 and Beyond
Hear timely updates from Norman E. Sharpless, MD, about accelerating progress in cancer, and the White House initiative of "Ending Cancer as We Know It."
Meet Dr. Sean Khozin, CEO of CancerLinQ
CancerLinQ CEO Dr. Sean Khozin talks about his new role, his background as a data scientist and oncologist, his vision and priorities for CancerLinQ, and current and future products.